Home › Myasthenia Gravis › Ohio › Cincinnati
Myasthenia Gravis clinical trials in Cincinnati, OH
5 studies for Myasthenia Gravis are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingPhase 3
- Site Number - 1038, Cincinnati
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
RecruitingPhase 3
- Mg0038 10102, Cincinnati
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RecruitingObservational study
- University of Cincinnati Medical Center - Goodman St, Cincinnati
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
RecruitingPhase 3
- University of Cincinnati, Cincinnati
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
RecruitingPhase 2
- University of Cincinnati Medical Center - Goodman St, Cincinnati
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL11 studies
- Houston, TX10 studies
- Durham, NC8 studies
- Columbus, OH8 studies
- Boca Raton, FL8 studies
- Milwaukee, WI7 studies
- Washington, DC6 studies
- Detroit, MI6 studies
- Miami, FL6 studies
- New York City, NY6 studies
- Philadelphia, PA6 studies
- Portland, OR6 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)26 studies
- Breast Cancer24 studies
- Heart Failure22 studies
- Metastatic Cancer21 studies
- Colorectal Cancer20 studies
- Obesity20 studies
- Acute Myeloid Leukemia20 studies
- Prostate Cancer19 studies
- Ovarian Cancer18 studies
- Lung Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.